Table 2.

Demographics and clinical characteristics

Clinical Characteristic	N (%)
Age
<40	53 (11)
40–49	112 (22)
50–59	150 (30)
60–69	132 (26)
≥70	53 (11)
Not stated	3 (1)
Sex
Female	500 (99)
Male	2 (0)
Prefer not to answer	1 (0)
Race *Multiple responses allowed
White/Caucasian	455 (90)
Hispanic/Latin American	24 (5)
African American/Black Caribbean	13 (3)
Asian	10 (2)
Native American	7 (1)
Indian (Indian Subcontinent)	5 (1)
Middle Eastern	3 (1)
African	2 (0)
Other	9 (2)
Not stated	6 (1)
Household Annual Income
<$15,000	16 (3)
$15,000-$24,999	25 (5)
$25,000-$49,999	62 (12)
$50,000-$74,999	71 (14)
$75,000-$99,999	73 (15)
>$100,000	180 (36)
Don’t know/prefer not to answer	76 (15)
Time since metastasis discovered
< 2 years	153 (30)
2 to 5 years	216 (43)
> 5 years	134 (27)
Number of regimens for metastatic breast cancer
None	7 (1)
1	111 (22)
2 to 5	291 (58)
6 or more	94 (19)
Current clinical situation
In remission or bone metastasis only, no evidence of active disease	144 (29)
Currently receiving treatment (stable, too early, or not responding)	351 (70)
No standard treatment options, palliative, seeking trials	8 (2)